Quarterly ResultJul 28, 2026, 04:07 PM
Incyte Q2 Revenue +37.7% to $1.67B; Net Income +44.6% to $585.6M
AI Summary
Incyte Corporation reported strong second-quarter 2026 financial results, with total revenues increasing by 37.7% to $1.67 billion and net income rising by 44.6% to $585.6 million. Diluted EPS grew by 37.7% to $2.81. The company saw significant growth in net sales, particularly for OPZELURA, which benefited from an agreement with CMS, and launched JAKAFI XR. Operating cash flow also saw a substantial increase.
Key Highlights
- Total revenues for Q2 2026 increased 37.7% to $1.67 billion.
- Net income for Q2 2026 rose 44.6% to $585.6 million.
- Diluted earnings per share for Q2 2026 increased 37.7% to $2.81.
- OPZELURA net sales surged 173.4% to $449.7 million in Q2 2026.
- JAKAFI net sales grew 6.9% to $816.7 million in Q2 2026.
- Net cash provided by operating activities was $877.0 million for H1 2026.
- Cash and cash equivalents totaled $3.98 billion as of June 30, 2026.
- JAKAFI XR was launched in Q2 2026, contributing to JAKAFI net sales.
Price Impact
More from INCY